Compare DVA & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVA | TFPM |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 6.8B |
| IPO Year | 2002 | 2022 |
| Metric | DVA | TFPM |
|---|---|---|
| Price | $152.23 | $38.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $156.75 | $35.33 |
| AVG Volume (30 Days) | ★ 1.4M | 526.1K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.84 | N/A |
| Revenue | ★ $13,643,069,000.00 | N/A |
| Revenue This Year | $3.80 | $17.71 |
| Revenue Next Year | $3.04 | N/A |
| P/E Ratio | ★ $15.66 | $35.57 |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $101.00 | $17.10 |
| 52 Week High | $159.42 | $41.70 |
| Indicator | DVA | TFPM |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 54.26 |
| Support Level | $135.14 | $32.31 |
| Resistance Level | N/A | $40.29 |
| Average True Range (ATR) | 4.63 | 1.39 |
| MACD | -0.32 | 0.33 |
| Stochastic Oscillator | 66.18 | 57.38 |
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.